BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15095397)

  • 21. Erythrocytapheresis (red cell exchange).
    Sentinella K; Thompson R; Hunt D; Simpson L; Marshall CE
    Prog Clin Biol Res; 1982; 106():425-35. PubMed ID: 7178144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults.
    Kalff A; Dowsing C; Grigg A
    Br J Haematol; 2010 Jun; 149(5):768-74. PubMed ID: 20346014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful pulmonary thromboendarterectomy in a patient with sickle cell disease treated with a single preoperative red blood cell exchange.
    Marques MB; Wille KM; Ren Z; Sheth M; McGiffin DC
    Transfusion; 2014 Jul; 54(7):1901-2. PubMed ID: 25041151
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients.
    Ahn H; Li CS; Wang W
    Pediatr Blood Cancer; 2005 Aug; 45(2):184-90. PubMed ID: 15747337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease.
    Tsitsikas DA; Seligman H; Sirigireddy B; Odeh L; Nzouakou R; Amos RJ
    Br J Haematol; 2014 Dec; 167(5):707-10. PubMed ID: 25041505
    [No Abstract]   [Full Text] [Related]  

  • 27. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sickle Cell Intrahepatic Cholestasis with Acute Liver Failure and Acute Kidney Injury: Favorable Outcome with Exchange Transfusion: Correspondence.
    Ghosh JB
    Indian J Pediatr; 2021 Feb; 88(2):200-201. PubMed ID: 32506366
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of corrected QT interval in sickle-cell disease patients who undergo erythroapheresis.
    Boga C; Kozanoglu I; Yeral M; Bakar C
    Transfus Med; 2007 Dec; 17(6):466-72. PubMed ID: 18067651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients.
    Kuo KH; Ward R; Kaya B; Howard J; Telfer P
    Br J Haematol; 2015 Aug; 170(3):425-8. PubMed ID: 25627922
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
    Thurston GB; Henderson NM; Jeng M
    Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of intra-heptic cholestasis in primary biliary cirrhosis by long term plasmapheresis.
    Vankeerberghen L; Oppenheimer M; Opolon P; Lévy VG
    Life Support Syst; 1983; 1 Suppl 1():106-11. PubMed ID: 6443835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sickle cell disease, extreme hyperbilirubinemia, and pericardial tamponade: case report and review of the literature.
    Khurshid I; Anderson L; Downie GH; Pape GS
    Crit Care Med; 2002 Oct; 30(10):2363-7. PubMed ID: 12394969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regular automated erythrocytapheresis in sickle cell patients.
    Driss F; Moh-Klaren J; Pela AM; Tertian G
    Br J Haematol; 2011 Sep; 154(5):656-9. PubMed ID: 21517812
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative evaluation of the depletion-red cell exchange program with the Spectra Optia and the isovolemic hemodilution-red cell exchange method with the COBE Spectra in sickle cell disease patients.
    Poullin P; Sanderson F; Bernit E; Brun M; Berdah Y; Badens C
    J Clin Apher; 2016 Oct; 31(5):429-33. PubMed ID: 26274351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of long-term erythrocytapheresis on splenic function in patients with sickle cell disease.
    Raj A; Bertolone S; Klapheke P; Burnett D; Suarez C
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):545-7. PubMed ID: 12368691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.
    Vichinsky EP
    Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146
    [No Abstract]   [Full Text] [Related]  

  • 38. Red cell transfusions for patients with sickle cell disease: do we have more to learn?
    Nuss R
    Pediatr Blood Cancer; 2010 Apr; 54(4):499-500. PubMed ID: 19998466
    [No Abstract]   [Full Text] [Related]  

  • 39. Rare but Lethal Hepatopathy-Sickle Cell Intrahepatic Cholestasis and Management Strategies.
    Malik A; Merchant C; Rao M; Fiore RP
    Am J Case Rep; 2015 Nov; 16():840-3. PubMed ID: 26613743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rare Complication of Sickle Cell Anemia.
    Surapaneni PK; Mills K; Renelus BD
    Gastroenterology; 2021 Jul; 161(1):45-46. PubMed ID: 33221401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.